World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×
Our website is made possible by displaying certain online content using javascript.
In order to view the full content, please disable your ad blocker or whitelist our website www.worldscientific.com.

System Upgrade on Mon, Jun 21st, 2021 at 1am (EDT)

During this period, the E-commerce and registration of new users may not be available for up to 6 hours.
For online purchase, please visit us again. Contact us at [email protected] for any enquiries.

Potential Targets for Treatment of Coronavirus Disease 2019 (COVID-19): A Review of Qing-Fei-Pai-Du-Tang and Its Major Herbs

    COVID-19 has been declared a pandemic by WHO on March 11, 2020. No specific treatment and vaccine with documented safety and efficacy for the disease have been established. Hence it is of utmost importance to identify more therapeutics such as Chinese medicine formulae to meet the urgent need. Qing Fei Pai Du Tang (QFPDT), a Chinese medicine formula consisting of 21 herbs from five classical formulae has been reported to be efficacious on COVID-19 in 10 provinces in mainland China. QFPDT could prevent the progression from mild cases and shorten the average duration of symptoms and hospital stay. It has been recommended in the 6th and 7th versions of Clinical Practice Guideline on COVID-19 in China. The basic scientific studies, supported by network pharmacology, on the possible therapeutic targets of QFPDT and its constituent herbs including Ephedra sinica, Bupleurum chinense, Pogostemon cablin, Cinnamomum cassia, Scutellaria baicalensis were reviewed. The anti-oxidation, immuno-modulation and antiviral mechanisms through different pathways were collated. Two clusters of actions identified were cytokine storm prevention and angiotensin converting enzyme 2 (ACE2) receptor binding regulation. The multi-target mechanisms of QFPDT for treating viral infection in general and COVID-19 in particular were validated. While large scale clinical studies on QFPDT are being conducted in China, one should use real world data for exploration of integrative treatment with inclusion of pharmacokinetic, pharmacodynamic and herb-drug interaction studies.

    References

    • Chan, K.W., V.T. Wong and S.C. Tang. COVID-19: An update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative Chinese-Western medicine for the management of 2019 novel coronavirus disease. Am. J. Chin. Med. 48: 1–26, 2020. Link, ISIGoogle Scholar
    • Chen, L., J. Dou, Z. Su, H. Zhou, H. Wang, W. Zhou, Q. Guo and C. Zhou. Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice. Antiviral Res. 91: 314–320, 2011. Crossref, Medline, ISIGoogle Scholar
    • Deng, Y.F., R.E. Aluko, Q. Jin, Y. Zhang and L.J. Yuan. Inhibitory activities of baicalin against renin and angiotensin-converting enzyme. Pharm. Biol. 50: 401–406, 2012. Crossref, Medline, ISIGoogle Scholar
    • Do, J.S., J.K. Hwang, H.J. Seo, W.H. Woo and S.Y. Nam. Antiasthmatic activity and selective inhibition of type 2 helper T cell response by aqueous extract of semen armeniacae amarum. Immunopharmacol. Immunotoxicol. 28: 213–225, 2006. Crossref, Medline, ISIGoogle Scholar
    • Fu, Y., X. Hu, Y. Cao, Z. Zhang and N. Zhang. Saikosaponin a inhibits lipopolysaccharide-oxidative stress and inflammation in human umbilical vein endothelial cells via preventing TLR4 translocation into lipid rafts. Free Radic. Biol. Med. 89: 777–785, 2015. Crossref, Medline, ISIGoogle Scholar
    • Garret, F. Misguided drug advice for COVID-19. Science, 2020, https://doi.org/10.1126/science.abb8034. ISIGoogle Scholar
    • Gerlach, H.. Agents to reduce cytokine storm. F1000Res. 5: 2909–2909, 2016. Crossref, MedlineGoogle Scholar
    • Guan, W.J., Z.Y. Ni, Y. Hu, W.H. Liang, C.Q. Ou, J.X. He, L. Liu, H. Shan, C.L. Lei, D.S.C. Hui, B. Du, L.J. Li, G. Zeng, K.Y. Yuen, R.C. Chen, C.L. Tang, T. Wang, P.Y. Chen, J. Xiang, S.Y. Li, J.L. Wang, Z.J. Liang, Y.X. Peng, L. Wei, Y. Liu, Y.H. Hu, P. Peng, J.M. Wang, J.Y. Liu, Z. Chen, G. Li, Z.J. Zheng, S.Q. Qiu, J. Luo, C.J. Ye, S.Y. Zhu and N.S. Zhong. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382: 1708–1720, 2020. Crossref, Medline, ISIGoogle Scholar
    • Guo, A., D. He, H.B. Xu, C.A. Geng and J. Zhao. Promotion of regulatory T cell induction by immunomodulatory herbal medicine licorice and its two constituents. Sci. Rep. 5: 14046–14046, 2015. Crossref, Medline, ISIGoogle Scholar
    • Hayyan, M., M.A. Hashim and I.M. AlNashef. Superoxide Ion: generation and chemical implications. Chem. Rev. 116: 3029–3085, 2016. Crossref, Medline, ISIGoogle Scholar
    • Jiang, P., S. Li, P. Liu, J. Peng and Q. Peng. Analysis of TCM prevention and treatment schemes for COVID-19 in various regions of China. Acta Chin. Med., 2020. Google Scholar
    • Jiang, Q. and X. Chen. Thoughts on Qingfei Paidu decoction for quickly treating new Coronavirus pneumonia based on syndrome differentiation. J. Tradit. Chin. Med., 2020. Google Scholar
    • Kallassy, H., M. Fayyad-Kazan, R. Makki, Y. El-Makhour, H. Rammal, D.Y. Leger, V. Sol, H. Fayyad-Kazan, B. Liagre and B. Badran. Chemical composition and antioxidant, anti-inflammatory, and antiproliferative activities of Lebanese Ephedra Campylopoda Plant. Med. Sci. Monit. Basic Res. 23: 313–325, 2017. Crossref, Medline, ISIGoogle Scholar
    • Ke, R.D., S.F. Lin, Y. Chen, C.R. Ji and Q.G. Shu. Analysis of chemical composition of polysaccharides from Poria cocos Wolf and its anti-tumor activity by NMR spectroscopy. Carbohydr. Polym. 80: 31–34, 2010. Crossref, ISIGoogle Scholar
    • Kim, S.O., J.Y. Park, S.Y. Jeon, C.H. Yang and M.R. Kim. Saikosaponin a, an active compound of Radix Bupleuri, attenuates inflammation in hypertrophied 3T3-L1 adipocytes via ERK/NF-κB signaling pathways. Int. Mol. Med. 35: 1126–1132, 2015. Crossref, Medline, ISIGoogle Scholar
    • Kuba, K., Y. Imai, S. Rao, H. Gao, F. Guo, B. Guan, Y. Huan, P. Yang, Y. Zhang, W. Deng, L. Bao, B. Zhang, G. Liu, Z. Wang, M. Chappell, Y. Liu, D. Zheng, A. Leibbrandt, T. Wada, A.S. Slutsky, D. Liu, C. Qin, C. Jiang and J.M. Penninger. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury. Nat. Med. 11: 875–879, 2005. Crossref, Medline, ISIGoogle Scholar
    • Lee, C.. Therapeutic modulation of virus-induced oxidative stress via the Nrf2-dependent antioxidative pathway. Oxid. Med. Cell. Longev. 2018: 6208067, 2018. Crossref, Medline, ISIGoogle Scholar
    • Lee, Y.H., C.L. Lai, S.H. Hsieh, C.C. Shieh, L.M. Huang and B.A. Wu-Hsieh. Influenza A virus induction of oxidative stress and MMP-9 is associated with severe lung pathology in a mouse model. Virus. Res. 178: 411–422, 2013. Crossref, Medline, ISIGoogle Scholar
    • Li, R., K. Sakwiwatkul, L. Yu and S. Hu. Enhancement of the immune responses to vaccination against foot-and-mouth disease in mice by oral administration of an extract made from Rhizoma Atractylodis Macrocephalae (RAM). Vaccine 27: 2094–2098, 2009. Crossref, Medline, ISIGoogle Scholar
    • Li, W., M.J. Moore, N. Vasilieva, J. Sui, S.K. Wong, M.A. Berne, M. Somasundaran, J.L. Sullivan, K. Luzuriaga, T.C. Greenough, H. Choe and M. Farzan. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426: 450–454, 2003. Crossref, Medline, ISIGoogle Scholar
    • Li, X., X. Li, N. Huang, R. Liu and R. Sun. A comprehensive review and perspectives onpharmacology and toxicology of saikosaponins. Phytomedicine 50: 73–87, 2018. Crossref, Medline, ISIGoogle Scholar
    • Lin, K.T., T.C. Chang, F.Y. Lai, C.S. Lin, H.L. Chao and S.Y. Lee. Rhodiola crenulata attenuates gamma-ray induced cellular injury via modulation of oxidative stress in human skin cells. Am. J. Chin. Med. 46: 175–190, 2018. Link, ISIGoogle Scholar
    • Lipsitch, M., D.L. Swerdlow and L. Finelli. Defining the epidemiology of Covid-19 - studies needed. N. Engl. J. Med. 382: 1194–1196, 2020. Crossref, Medline, ISIGoogle Scholar
    • Liu, Z.Q.. Anti-oxidant in China: A thirty-year journey. Am. J. Chin. Med. 47: 1005–1024, 2019. Link, ISIGoogle Scholar
    • Lu, C.N., Z.G. Yuan, X.L. Zhang, R. Yan, Y.Q. Zhao, M. Liao and J.X. Chen. Saikosaponin a and its epimer saikosaponin D exhibit anti-inflammatory activity by suppressing activation of NF-κB signaling pathway. Int. Immunopharmacol. 14: 121–126, 2012. Crossref, Medline, ISIGoogle Scholar
    • Lu, Y.T., Y.C. Kuan, H.H. Chang and F. Sheu. Molecular cloning of a Poria cocos protein that activates Th1 immune response and allays Th2 cytokine and IgE production in a murine atopic dermatitis model. J. Agric. Food Chem. 62: 2861–2871, 2014. Crossref, Medline, ISIGoogle Scholar
    • Lu, R., W. Wang and X. Li. Clinical observation on 63 cases of suspected cases of new coronavirus pneumonia treated by Chinese medicine Lianhua Qingwen. J. Tradit. Chin. Med., 2020. Google Scholar
    • Ma, C.H., Z.Q. Ma, X.L. Liao, J.P. Liu, Q. Fu and S.P. Ma. Immunoregulatory effects of Glycyrrhizic acid exerts anti-asthmatic effects via modulation of Th1/Th2 cytokines and enhancement of CD4+CD25+Foxp3+ regulatory T cells in ovalbumin-sensitized mice. J. Ethnopharmacol. 148: 755–762, 2013. Crossref, Medline, ISIGoogle Scholar
    • Ma, Y., Y. R. Bao, S. Wang, T. J. Li, X. Chang, G. L. Yang and X. S. Meng. Anti-inflammation effects and potential mechanism of Saikosaponins by regulating nicotinate and nicotinamide metabolism and arachidonic acid metabolism. Inflammation 239(4): 1453–1461, 2016. CrossrefGoogle Scholar
    • Ma, J., M. Chen and Y. Wang. Summary of TCM syndromes and treatment of new coronavirus (2019-nCoV) syndrome. Beijing. J. Tradit. Chin. Med., 2020. Google Scholar
    • Madjid, M., P. Safavi-Naeini, S.D. Solomon and O. Vardeny. Potential effects of coronaviruses on the cardiovascular system: A review. JAMA Cardiol. 2020, https://doi.org/10.1001/jamacardio.2020.1286. Crossref, MedlineGoogle Scholar
    • National Health Comission and National Administration of Traditional Chinese Medicine. Diagnosis and treatment of pneumonia caused by new coronavirus (trial version 7). National Health Comission, National Administration of Traditional Chinese Medicine, Beijing, 2020. Google Scholar
    • Ohno, H., S. Miyoshi, D. Araho, T. Kanamoto, S. Terakubo, H. Nakashima, T. Tsuda, K. Sunaga, S. Amano, E. Ohkoshi, H. Sakagami, K. Satoh and M. Yamamoto. Efficient utilization of licorice root by alkaline extraction. In Vivo 28: 785–794, 2014. Medline, ISIGoogle Scholar
    • Okawa, M., J. Kinjo, T. Nohara and M. Ono. DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging activity of flavonoids obtained from some medicinal plants. Biol. Pharm. Bull. 24: 1202–1205, 2001. Crossref, Medline, ISIGoogle Scholar
    • Park, C.H., A.Y. Lee, J.H. Kim, S.H. Seong, G.Y. Jang, E.J. Cho, J.S. Choi, J. Kwon, Y.O. Kim, S.W. Lee, T. Yokozawa and Y.S. Shin. Protective effect of safflower seed on cisplatin-induced renal damage in mice via oxidative stress and apoptosis-mediated pathways. Am. J. Chin. Med. 46: 157–174, 2018. Link, ISIGoogle Scholar
    • Sanchis-G, F., C.J. Lavie, P.-Q. Carme, M.H. Brandon and G. Lippi. Angiotensin-converting enzyme 2 and anti-hypertensives (angiotensin receptor blockers and angiotensin converting enzyme inhibitors) in Coronavirus Disease 2019 (COVID-19). J. Mayocp. 95(6): 1222–1230, 2020. Google Scholar
    • Sohn, E.J., J.M. Kim, S.H. Kang, J. Kwon, H.J. An, J.S. Sung, K.A. Cho, I.S. Jang and J.S. Choi. Restoring effects of natural anti-oxidant quercetin on cellular senescent human dermal fibroblasts. Am. J. Chin. Med. 46: 853–873, 2018. Link, ISIGoogle Scholar
    • Tignanelli, C.J., N.E. Ingraham, M.A. Sparks, R. Reilkoff, T. Bezdicek, B. Benson, T. Schacker, J.G. Chipman and M.A. Puskarich. Antihypertensive drugs and risk of COVID-19?. Lancet Respir. Med. 8(5): e28, 2020. Crossref, MedlineGoogle Scholar
    • Vaduganathan, M., O. Vardeny, T. Michel, J.J.V. McMurray, M.A. Pfeffer and S.D. Solomon. Renin-Angiotensin-Aldosterone system inhibitors in patients with Covid-19. N. Engl. J. Med. 382: 1653–1659, 2020. Crossref, Medline, ISIGoogle Scholar
    • Wang, R.Q., S.J. Yang, C.G. Xie, Q.L. Shen, M.Q. Li, X. Lei, J.K. Li and M. Huang. Clinical observation of Qingfeipaidu Decoction in the treatment of novel coronavirus pneumonia. Pharmacol. Chin. Mat. Med., 2020a. Google Scholar
    • Wang, Y., W. Qi, J. Ma, L. Ruan, Y. Lu, X. Li, X. Zhao, Z. Zhang and Q. Liu. TCM clinical features and syndrome differentiation of new coronavirus (2019-nCoV) pneumonia. J. Tradit. Chin. Med. 61: 1–7, 2020b. Google Scholar
    • Wei, W.Y., H.X. Du, C.Y. Shao, H.F. Zhou, Y.Y. Lu, L. Yu, H.T. Wan and Y. He. Screening of antiviral components of ma huang tang and investigation on the ephedra alkaloids efficacy on influenza virus type A. Front. Pharmacol. 10: 961, 2019. Crossref, Medline, ISIGoogle Scholar
    • Wei, X.L., X.Y. Zhu, N. Hu, X.Q. Zhang, T.J. Sun, J.Y. Xu and X.H. Bian. Baicalin attenuates angiotensin II-induced endothelial dysfunction. Biochem. Biophys. Res. Commun. 465: 101–107, 2015. Crossref, Medline, ISIGoogle Scholar
    • Wu, X.L., D.H. Ju, J. Chen, B. Yu, K.L. Liu, J.X. He, C.Q. Dai, S. Wu, Z. Chang, Y.P. Wang and X.Y. Chen. Immunologic mechanism of Patchouli alcohol anti-H1N1 influenza virus may through regulation of the RLH signal pathway in vitro. Curr. Microbiol. 67: 431–436, 2013. Crossref, Medline, ISIGoogle Scholar
    • Wu, Y.J., S. Li, H.X. Li, C.Z. Zhao, H. Ma, X.N. Zhao, J.H. Wu, K.L. Liu, J.J. Shan and Y.X. Wang. Effect of a polysaccharide from Poria cocos on humoral response in mice immunized by H1N1 influenza and HBsAg vaccines. Int. J. Biol. Macromol. 91: 248–257, 2016. Crossref, Medline, ISIGoogle Scholar
    • Wu, H., J.Q. Wang, Y.W. Yang, T.Y. Li, Y.J. Cao, Y.X. Qu, Y.J. Jin, C.N. Zang and Y.K. Sun. Preliminary exploration of the mechanism of Qingfei Paidu decoction against novel coronavirus pneumonia based on network pharmacology and molecular docking technology. Acta Pharm. Sinica 1–18, 2020. Google Scholar
    • Xia, W., C. An, Y. Zheng, J. Zhang, M. Huang, Y. Wang, F. Yang, C. Duan and Z. Li. Clinical study on 34 cases of new coronavirus pneumonia treated with integrated traditional Chinese and Western medicine. J. Tradit. Chin. Med., 2020. MedlineGoogle Scholar
    • Xian, Y.F., Y.C. Li, S.P. Ip, Z.X. Lin, X.P. Lai and Z.R. Su. Anti-inflammatory effect of patchouli alcohol isolated from Pogostemonis Herba in LPS-stimulated RAW264.7 macrophages. Exp. Ther. Med. 2: 545–550, 2011. Crossref, Medline, ISIGoogle Scholar
    • Xu, W., R. Guan, F.S. Shi, A.F. Du and S.H. Hu. Structural analysis and immunomodulatory effect of polysaccharide from Atractylodis macrocephalae Koidz. on bovine lymphocytes. Carbohydr. Polym. 174: 1213–1223, 2017. Crossref, Medline, ISIGoogle Scholar
    • Xu, D., Y. Xu, Z. Wang, Y. Lu, H. Zhu and T. Song. Mechanism of qingfeipaidu decoction on COVID-19 based on network pharmacology. Pharmacol. Chin. Mat. Med., 2020. Google Scholar
    • Yang, L., Y. T. Yang, T. Miao, L. Wang, H. Fu, Q. Li, W. B. Wen, Z. Y. Zhang, R. W. Song, X. G. Liu, H. W. Wang and H. T. Cui. Network pharmacology studies on the effect of Chai-Ling decoction in coronavirus disease. J. Tradit. Chin. Med. 12: 1–15, 2019. Google Scholar
    • Yao, K., M. Liu, X. Li, J. Huang and H. Cai. Retrospective clinical analysis on treatment of novel coronavirus-infected pneumonia with traditional Chinese medicine Lianhua Qingwen. Chin. J. Exper. Tradit. Med. Formula, 2020. Google Scholar
    • Yoon, S.B., Y.J. Lee, S.K. Park, H.C. Kim, H.S. Bae, H.M. Kim, S.G. Ko, H.Y. Choi, M.S. Oh and W.S. Park. Anti-inflammatory effects of Scutellaria baicalensis water extract on LPS-activated RAW 264.7 macrophages. J. Ethnopharmacol. 125: 286–290, 2009. Crossref, Medline, ISIGoogle Scholar
    • Yue, G.G.L., B.C.L. Chan, H.F. Kwok, M.H. To, K.L. Hon, K.P. Fung, C.B.S. Lau and P.C. Leung. Screening for anti-inflammatory and bronchorelaxant activities of 12 commonly used Chinese herbal medicines. Phytother. Res. 26: 915–925, 2012. Crossref, Medline, ISIGoogle Scholar
    • Zhang, H.B., J.M. Penninger, Y.M. Li, N.S. Zhong and A.S. Slutsky. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target. Intensive Care. Med. 46: 586–590, 2020. Crossref, Medline, ISIGoogle Scholar
    • Zhao, B.S., H.R. Huo, Y.Y. Ma, H.B. Liu, L.F. Li, F. Sui, C.H. Li, S.Y. Guo and T.L. Jiang. Effects of 3-phenyl-propenal on the expression of toll-like receptors and downstream signaling components on raw264.7 murine macrophages. Am. J. Chin. Med. 36: 159–169, 2008. Link, ISIGoogle Scholar
    • Zhao, J., S.S. Tian, J. Yang, J.F. Liu and W.D. Zhang. Investigating the mechanism of Qing-Fei-Pai-Du-Tang for the treatment of novel coronavirus pneumonia by network pharmacology. Chin. Tradit. Herbal Drugs, 2020. Google Scholar
    • Zhi, H.J., H.Y. Zhu, Y.Y. Zhang, Y. Lu, H. Li and D.F. Chen. In vivo effect of quantified flavonoids-enriched extract of Scutellaria baicalensis root on acute lung injury induced by influenza A virus. Phytomedicine 57: 105–116, 2019. Crossref, Medline, ISIGoogle Scholar
    • Zhu, H.Y., L. Han, X.L. Shi, B.L. Wang, H. Huang, X. Wang, D.F. Chen, D.W. Ju and M.Q. Feng. Baicalin inhibits autophagy induced by influenza A virus H3N2. Antivir. Res. 113: 62–70, 2015. Crossref, Medline, ISIGoogle Scholar
    Published: 1 July 2020
    Remember to check out the Most Cited Articles!

    Check out our Chinese Medicine Titles today.
    Includes titles by Nobel Winner, Tu You You and more!